Sort
1,049,261 grants matching “t cell”
TOWARDS A MOLECULAR CLASSIFICATION OF TUMORS
$2,032,480University Of Michigan At Ann Arbor · U19 · FY2002 · CA
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$2,032,463Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Role of mitochondria in neurodegenerative diseases
$2,032,412Richard Youle · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS
Induction and maintenance of regulatory T cells
$2,032,400Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2011 · AI
Molecular Profiling of Clinical Specimens
$2,032,400Daniel Edelman · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Center for Alzheimer's and Related Dementias: iPSCs to study APOE heterogeneity in Alzheimers disease and Alzheimers disease-related dementias (iDA)
$2,032,391Mark Cookson · National Institute On Aging · ZIA · FY2025 · AG
ENGINEERED CARDIAC MORPHOGENESIS--STEM CELLS &SCAFFOLDS
$2,032,366University Of Washington · R24 · FY2004 · HL
Pathogenesis of E. coli and Shigella infections in human enteroid models
$2,032,323James B Kaper · University Of Maryland Baltimore · P01 · FY2022 · AI
IDENTIFYING GENES IN ABNORMAL BLOOD PRESSURE
$2,032,303Boston University Medical Campus · P50 · FY2005 · HL
Center for Dietary Supplements and Inflammation
$2,032,289Prakash S. Nagarkatti · University Of South Carolina At Columbia · P20 · FY2014 · GM
Functional genomics of breast cancer
$2,032,281Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
CLINICAL AND LABORATORY STUDIES OF MALIGNANT LYMPHOMAS
$2,032,209Stanford University · P01 · FY2001 · CA
SPORE in Genitourinary Cancer
$2,032,000Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2012 · CA
Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration
$2,031,992Valter D. Longo · University Of Southern California · P01 · FY2020 · AG
FORMIC ACID-BASED HYDROGEN ENERGY PRODUCTION AND DISTRIBUTION SYSTEM THE PRIMARY GOAL OF THIS PROJECT IS TO DEVELOP AND DEMONSTRATE AT AN INDUSTRIALLY RELEVANT SIZE AN END-TO-END COST-EFFECTIVE HIGH PERFORMANCE NOVEL CLEAN LIQUID HYDROGEN CARRIER PRODUCTION, DISTRIBUTION AND DISPENSING SUPPLY CHAIN USING FORMIC ACID AS THE LIQUID HYDROGEN CARRIER. THIS OVERALL PROJECT OBJECTIVE WILL BE ACHIEVED OVER TWO 12-MONTH BUDGET PERIODS WITH THE FOLLOWING OBJECTIVES ORGANIZED BY BUDGET PERIOD. BUDGET PERIOD 1 ACHIEVE TWO OF THE PERFORMANCE TARGETS PRECISELY AT STATED TARGET VALUES (HYDROGEN PRODUCTION RATE OF 0.01 KG/HR, FORMATE ELECTROLYZER FARADAIC EFFICIENCY OF 80%) AND THE REST OF THE PERFORMANCE TARGETS WITHIN A +/- 20% VARIANCE: 1. DEMONSTRATE THE ELECTROCATALYTIC CONVERSION OF CO2 AND WATER DIRECTLY INTO THE LIQUID HYDROGEN CARRIER FORM OF FORMIC ACID, AT AN >85% PURITY AND AT A PRODUCTION RATE OF APPROXIMATELY 37.5 KG PER DAY (H2 EQUIVALENT: 1.4 KG/DAY) USING AN INDUSTRIAL-SIZE HEIGHT (1.2M) AND WIDTH (1.35M) ELECTROLYZER CELL AT A FARADAIC EFFICIENCY AT OR ABOVE 80% FOR >100 HOURS OF OPERATION. THE SYSTEM INCLUDES THE INTERMEDIATE PRODUCTION OF FORMATE WHICH IS HYDROLYZED TO SYNTHESIZE FORMIC ACID AND TO RECYCLE THE POTASSIUM CHARGE CARRIER IN THE FORM OF POTASSIUM BICARBONATE. 2. DEMONSTRATE THE GENERATION, PURIFICATION, AND RELEASE OF HYDROGEN GAS, FROM THE DECOMPOSITION OF 85% PURITY FORMIC ACID, AT A RATE OF 0.01 KG/HOUR., AT A PURITY OF > 98.7% FOR >24 HOURS OF OPERATION USING A 10X MORE FRUGAL LOADING OF CATALYST THAN HAS BEEN ACHIEVED AT SMALLER SCALE. BUDGET PERIOD 2 ACHIEVE THE FOLLOWING PERFORMANCE TARGETS WITHIN A +/- 10% VARIANCE: 1. DEMONSTRATE THE ELECTROCATALYTIC CONVERSION OF CO2 AND WATER INTO THE LIQUID HYDROGEN CARRIER FORM OF FORMIC ACID, AT AN >85% PURITY AND AT A PRODUCTION RATE OF APPROXIMATELY 150 KG PER DAY (H2 EQUIVALENT: 5.6 KG/DAY) USING FOUR INDUSTRIAL-SIZE HEIGHT (1.2M) AND WIDTH (1.35M) ELECTROLYZER CELLS, IN A SKID-MOUNTED MODULE AT A FARADAIC EFFICIENCY AT OR ABOVE 80% FOR >240 HOURS OF OPERATION. THE SYSTEM WILL BE ENGINEERED AND OPERATED CONTINUOUSLY INCLUDING KEY INTERMEDIATE PROCESSES. 2. DEMONSTRATE THE SAFE STORAGE, HANDLING, AND TRANSPORT OF FORMIC USING EXISTING LIQUID HYDROCARBON DISTRIBUTION INFRASTRUCTURE AT AMBIENT TEMPERATURE AND PRESSURE CONDITIONS. 3. DEMONSTRATE THE GENERATION, PURIFICATION, AND RELEASE OF HYDROGEN GAS, FROM THE DECOMPOSITION OF 85 WT.% FORMIC ACID PRODUCED FROM THE ELECTROLYZER, AT A RATE OF 1.0 KG/HR., AT A PURITY OF >99.7% FOR >24 HOURS OF OPERATION.
$2,031,989Oco, Inc · · FY2023 · Department of Energy
DNA Sequencing and FACS Core Facilities
$2,031,947Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
Modifications to improve HIV neutralizing antibodies
$2,031,941John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Induction and maintenance of regulatory T cells
$2,031,918Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2014 · AI
Induction and maintenance of regulatory T cells
$2,031,918Mitchell Kronenberg · La Jolla Institute For Immunology · P01 · FY2012 · AI
Molecular and Genomic Imaging Center
$2,031,785Harvard University (Medical School) · P50 · FY2005 · HG
Machine learning and artificial intelligence research for clinical medical image processing
$2,031,730Sameer Antani · National Library Of Medicine · ZIA · FY2022 · LM
Cellular Senescence and Aging
$2,031,719James L. Kirkland · Mayo Clinic Rochester · P01 · FY2014 · AG
Alzheimer's DIsease Research Center
$2,031,585Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · AG
CAR-T Therapy of Mesothelin Expressing Cancers
$2,031,577Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Loss of miR-29s as predictor of response to demethylating agents
$2,031,555Carlo M Croce · Ohio State University · RC2 · FY2009 · CA